Fil Ltd Position in Mylan N V (NASDAQ:MYL) Upped by $14.07 Million as Price Declined

May 16, 2018 - By Noel Courtney

Mylan N.V. (NASDAQ:MYL) Corporate LogoDuring Q4 2017 the big money sentiment increased to 3. That’s change of 2.67, from 2017Q3’s 0.33. 0 investors sold all, 1 reduced holdings as MYL ratio increased. 0 rose positions while 3 funds took positions. Funds hold 292,846 shares thus 88.91% more from 2017Q3’s 155,019 shares. Gulf Comml Bank (Uk) Ltd owns 139,930 shs for 0.08% of their capital. Vantage Investment Advisors Ltd holds 0% or 337 shs in its capital. Moreover, Mirae Asset has 0.01% invested in Mylan N.V. (NASDAQ:MYL) for 17,231 shs. Van Hulzen Asset Mgmt Llc accumulated 120,545 shs.

Fil Ltd’s holdings in Mylan N V (NASDAQ:MYL) was increased by 6.62% based on its latest 2018Q1 report with the SEC. Mylan N V (NASDAQ:MYL) declined 5.99% with the market as Fil Ltd bought 343,102 shares. In 2018Q1, Fil Ltd held 5.52 million shares of Mylan N V (NASDAQ:MYL), valued at $227.35 million, up from 5.18 million last quarter. $20.17B is the MC of Mylan N V. MYL touched $39.18 during the last trading session after $0.68 change.Currently Mylan N.V. is downtrending after 5.23% change in last May 16, 2017. MYL has 3.20 million shares volume. The stock underperformed the S&P 500 by 16.78%.

Fil Ltd operates about $36.38B US longs. It reduced its stake in Ctrip Com Intl Ltd (Prn) () by 15.00 million shares to 26.00M shares, valued at $27.20 million in 2018Q1, according to the report. It decreased Mastercard Incorporated (NYSE:MA) position by 185,514 shares to 546,417 shares, and cut its Verisk Analytics Inc (NASDAQ:VRSK) stake.

Mylan N.V. (NASDAQ:MYL) Ratings Coverage

A total of 14 analysts rate Mylan Inc (NASDAQ:MYL) as follows: 11 “Buy”, 3 “Hold” and 0 “Sell”. Тherefore 79% are bullish. (NASDAQ:MYL) has 20 ratings reports on 16 May 2018 according to StockzIntelligence. On Thursday, January 4 the stock has “Buy” rating by Citigroup. The company rating was upgraded by Goldman Sachs on Thursday, January 11. On Thursday, December 21 Cantor Fitzgerald maintained the shares of MYL in report with “Hold” rating. On Tuesday, December 12 the company was initiated by Guggenheim. On Thursday, April 12 the firm has “Outperform” rating given by Leerink Swann. The stock rating was maintained by Mizuho with “Buy” on Thursday, April 12. The stock rating was maintained by Wells Fargo with “Hold” on Thursday, January 18. The stock rating was upgraded by Morgan Stanley to “Overweight” on Tuesday, March 6. On Thursday, January 18 Mizuho maintained Mylan N.V. (NASDAQ:MYL) with “Buy” rating. On Monday, April 9 Morgan Stanley maintained Mylan N.V. (NASDAQ:MYL) rating. Morgan Stanley has “Buy” rating and $5000 target.

Mylan N.V., together with its subsidiaries, develops, licenses, makes, markets, and distributes generic, brand name, and over-the-counter products worldwide.The company has $20.17 billion market cap. The firm operates through three divisions: North America, Europe, and Rest of World.The P/E ratio is 30.14. It offers pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized, and cream or ointment forms.

Mylan N.V. (NASDAQ:MYL) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.